← Back to Clinical Trials
Recruiting NCT06644222

NCT06644222 Effectiveness of Airrosti and TheraBand Exercises on Double-Crossed Syndrome in Smart Phone User's Shoulder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06644222
Status Recruiting
Phase
Sponsor Majmaah University
Condition Rounded Shoulder Posture
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-12-10
Primary Completion 2025-12-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
AIRROSTI exercisesThera band exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-12-10 with a primary completion date of 2025-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Double-crossed syndrome" refers to a specific alignment of overactive and underactive muscles in the neck, chest, and shoulders. AIRROSTI stands for Applied Integration for the Rapid Recovery of Soft Tissue Injuries. This study aims to evaluate the effectiveness of Airrosti exercises combined with TheraBand exercises in reducing pain and disability in the neck and shoulders. TheraBand exercise programs are commonly used to improve muscle activation. However, research on the effectiveness of AIRROSTI combined with TheraBand exercises for treating Double-Crossed Syndrome among smartphone users is limited, and more evidence is needed to support their effectiveness.

Eligibility Criteria

Inclusion Criteria: young female participants with rounded shoulder postures. Participants aged between 18 and 25 years. No history of shoulder trauma, current shoulder pathology, thoracic scoliosis, and kyphosis deformity. Exclusion Criteria: Participants excluded if they received any other form of medical treatment or have thoracic scoliosis or kyphosis deformity.

Contact & Investigator

Central Contact

Shahnaz Hasan, PhD

✉ sh.ahmad@mu.edu.sa

📞 +966550303481

Principal Investigator

Shahnaz Hasan associate Professor, PhD

PRINCIPAL INVESTIGATOR

Majmaah University

Frequently Asked Questions

Who can join the NCT06644222 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 25 Years, studying Rounded Shoulder Posture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06644222 currently recruiting?

Yes, NCT06644222 is actively recruiting participants. Contact the research team at sh.ahmad@mu.edu.sa for enrollment information.

Where is the NCT06644222 trial being conducted?

This trial is being conducted at Al Majma'ah, Saudi Arabia.

Who is sponsoring the NCT06644222 clinical trial?

NCT06644222 is sponsored by Majmaah University. The principal investigator is Shahnaz Hasan associate Professor, PhD at Majmaah University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology